Inclusion criteria. by Heloisa Ricci Conesa (18291210)

Subjects:

PRISMA flow diagram for the literature search. by Heloisa Ricci Conesa (18291210)

Subjects:

Estimates for direct medical and total costs per AOM episode (2020 EUR), by country [35, 96–100]. by Heloisa Ricci Conesa (18291210)

Subjects:

Overview regarding the used assays and observation time points. by Fabian Westhauser (5314436)

FLIM-FRET measurements with KIRIN1 sensor detects relative changes in intracellular K⁺. by Xiaowen Jiang (8291814)

“…<b>(Ab)</b> FLIM-FRET measurements of the KIRIN1 sensor expressed in the same cells that were patched in Aa detected decreases in intracellular K⁺ in cells expressing CMV:<i>kcnk5b</i>-mCherry (blue) compared to cells lacking the expression of the channel (CMV:mCherry, red). …”

Dox-inducible expression of HA-MAD1 in colon is sufficient to decrease p53 expression and cause chromosome missegregation. by Sarah E. Copeland (13951506)

“…Large circles show mean of cells from 5 fields of view from a single animal. (D) Immunoblot showing p53 protein expression is decreased in colon tissue from 5-month old HA-MAD1 mice after 1 week of 6 mg/kg dox feed as compared to control. …”

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10^-5), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10^-5), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10^-22), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10^-71), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10^-28), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10^-12), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10^-10) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10^-17). …”

Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>. by Wanjun Qi (5571359)

LOH at <i>KSR1</i> affects cellular lipid profiles, intracellular FLC concentrations, drug efflux, and sterol levels. by Pétra Vande Zande (17628246)

Cullin-1/5 degradation requires <i>Eh</i>CP-A1 and <i>Eh</i>CP-A4 but independent of <i>Eh</i>CP-A5. by Attinder Chadha (11414273)

Subjects:

Chimera and wild-type virus replication at early time points. by Anja vom Hemdt (19787189)

Graphs showing average growth cone area of control, 0.5% stretched, 5% stretched and repetitive very mild (2×0.5%) stretched axons at different time point. by Yiing C. Yap (4003037)

“…<p>There was a significant decrease in growth cone size after single stretch injury at both 24 h and 72 h PI and after repetitive very mild (2×0.5%) stretch injury at 72 h PI compared to control. …”

Step-wise evolution of drug resistance via CNV and LOH. by Pétra Vande Zande (17628246)

Effects of A1AR expression on response to hypoxia at E9.5 and E12.5. by Daniela L. Buscariollo (140729)

“…In hypoxia, E9.5 A1AR +/− heart rates decreased then returned to baseline levels following recovery in room air (p<0.0001 and p<0.01, for t = 25 and t = 40 compared to t = 0, respectively). …”

Klf5 and eIF5a suppress Ang II–induced expression of NOX1 in VSMCs. by Dong Ma (584680)

Subjects:

Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

“…<p>(A) DAOY cells were treated with CHX (100 μg/ml) for either 6 or 14 hours; for metabolic RNA labelling, 5-EU was added 2 hours before the sample collection. …”

Effects of SNPs on the Protein Stability, Increasing or Decreasing. by Mirza Jawad Ul Hasnain (8351388)

Kcnk5b enhanced depolarization is required for enhanced fin bud growth. by Xiaowen Jiang (8291814)

Structural details for each point mutation studied by X-ray crystallography in this study. by Aleksi Sutinen (10039145)

Subjects:

DO rather than depth affects taxa distributions and twenty-five taxa were identified as indicators of different DO conditions. by Rachel L. Spietz (782905)